Dr. Alexandra Jamie Coromilas, MD

Dr. Coromilas practices at Trustees of Columbia University in the City of New York in Fort Lee, New Jersey.

Dr. Coromilas' NPI, 1871972703, was assigned on May 26, 2015. Dr. Coromilas graduated from Vagelos College of Physicians and Surgeons in 2015. Dr. Coromilas holds New York license 293813.

Dr. Coromilas' primary practice is Trustees of Columbia University in the City of New York, at 400 Kelby St, Fort Lee, NJ 07024 in Bergen County. The practice phone is (646) 317-7111.

Dr. Coromilas' primary practice is Trustees of Columbia University in the City of New York in Fort Lee, New Jersey. Dr. Coromilas is also affiliated with NewYork-Presbyterian/Weill Cornell Medical Center. The medical group on file is ColumbiaDoctors. Dmand AI also links Dr. Coromilas to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Coromilas practices, 2 sites in all. Vendor and product names are available with a free account.

Dermatology is Dr. Coromilas' primary specialty in the NPI Registry, under taxonomy code 207N00000X. Dr. Coromilas is board certified in dermatology by the American Board of Dermatology. Dmand AI has Dr. Coromilas' licenses on file in 3 states: New York, Pennsylvania and Massachusetts.

Dmand AI lists acne, benign or precancerous skin growths, contact dermatitis, corns and calluses, hives, itchy rashes, joint cyst and psoriasis among the conditions Dr. Coromilas treats.

CMS data shows 1,345 Medicare services from Dr. Coromilas across 14 procedure codes in 2024, for 573 Medicare patients. Medicare paid $102,853 for them.

CMS counts 573 Medicare patients who saw Dr. Coromilas in 2024. The largest group is 65 to 74, with 229 patients. 74% of them have high cholesterol, and 68% have high blood pressure. 19% are also on Medicaid. Their average risk score is 1.65, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Coromilas' median patient age at 57, with 64% women.

In 2024, Dr. Coromilas wrote 1,993 Medicare Part D claims for 513 patients. 88% of them were for generic drugs. CMS names the drug for 1,700 of them, across 32 drugs with 11 or more claims each, at $570,701 in total drug cost. In 2023, CMS named 914 claims across 24 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Coromilas for performance year 2024, reported through an alternative payment model (APM). Dr. Coromilas accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Coromilas as offering telehealth. CMS counts 174 procedures of skin biopsy by Dr. Coromilas, more than 83% of the clinicians it reports for that procedure.

Dmand AI links 27 papers to Dr. Coromilas, published from 2014 to 2025. 2022 was the busiest year, with 5. The most frequent topics are Diarrhea, Immune Checkpoint Inhibitors and Biopsy. Dr. Coromilas has published most often in JAAD Case Rep. Dr. Coromilas' most frequent co-authors are Stephanie Marie Gallitano, MD, Sameera Husain, MD and Robert Gil Micheletti, MD.

CMS Open Payments shows 16 general payments to Dr. Coromilas from 9 drug and device companies from 2018 to 2025. Food and beverage make up the largest share, 97% of the total. Abbvie Inc. paid the most, $214.

Dr. Coromilas graduated from Vagelos College of Physicians and Surgeons in 2015.

Dr. Coromilas is in network with 15 carriers, including Aetna, Excellus BlueCross BlueShield and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 11. Check the plan with the practice before a visit.